DRL

Location

Vlaams Brabant

Founded

1980-09-05

Risk Signals

105 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about DRL

Live alerts from global media, monitored by Business Radar

Hybrid turn for Lamborghini Urus Performmante -

2025-07-07 (newsauto.gr)

Hybrid turn for Lamborghini Urus Performmante -

The Lamborghini Urus Performante is preparing for a hybrid upgrade with a brand new engine.

Read more
DRL to distribute Sanofi's Beyfortus, used to prevent RSV in infants - The Hindu

2025-04-28 (thehindubusinessline.com)

DRL to distribute Sanofi's Beyfortus, used to prevent RSV in infants - The Hindu

Dr Reddy's and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.

Read more
Maruti Suzuki Fronx Launched In India Newest Maruti With Turbo Petrol Engine Check Prices Features Photos Details

2023-04-24 (abplive.com)

Maruti Suzuki Fronx Launched In India Newest Maruti With Turbo Petrol Engine Check Prices Features Photos Details

The Fronx is a coupe SUV based on the Baleno and was first unveiled at the 2023 Auto Expo. After the Baleno RS, the Fronx is the newest Maruti to get turbo petrol.

Read more
DRL, Natco rise on nod for Revlimid copy -

2021-09-02 (thehindu.com)

DRL, Natco rise on nod for Revlimid copy -

Business News:DRL, Natco rise on nod for Revlimid copy

Read more
DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients

2021-06-28 (business-standard.com)

DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients

Dr Reddy's Laboratories (DRL) commercially launched 2-deoxy-D-glucose (2-DG), a drug used for treating Coronavirus (Covid-19) patients, priced at Rs 990 for a...

Read more
DRL receives US FDA approval -

2018-10-15 (expresspharma.in)

DRL receives US FDA approval -

The company has received the approval for Aspirin and Extended-Release dipyridamole capsules in the US Market Dr Reddy's Labs, (DRL) recently announced receipt of approval for Aspirin and Extended-Release dipyridamole capsules, […]

Read more
DRL launches nitroglycerin sublingual tablets in US -

(economictimes.com)

DRL launches nitroglycerin sublingual tablets in US -

The drug which is used in preventing or relieving a sudden attack of angina (chest pain) caused by heart disease was approved by the USFDA.

Read more

Never miss a headline about DRL

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages